coteauBeta Get App

AGL

agilon health, inc.
$90.29
-0.77% Oct 22 close
Healthcare CompareTechnicals
-68%+65%+199%+332%+466%Oct 2025Oct 2026Apr 202652w high $133.0452w low $7.48
AGLSPY
1W
+2.1%
1M
+4.0%
3M
-10.0%
6M
+243.0%
YTD
+424.2%
1Y
+283.4%

Live chart

Loading live chart…

What they do

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was founded in 2016 and is based in Westerville, Ohio.

Healthcare · Medical Care Facilities

For information only · Important disclosures

Grades vs sector

No sector grades for AGL yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 5 live models right now.

Quality Growth
Outside this model's universe or screens
Momentum Top 15
Outside this model's universe or screens
Momentum Blend
Not in the current book
New Highs Growth
Outside this model's universe or screens
Coteau Long Book
Not in the current book

News

More news
agilon health (AGL): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · Oct 21
Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know
StockStory · Oct 19
2 High-Flying Stocks with Competitive Advantages and 1 We Question
StockStory · Oct 16
Why Did agilon health (AGL) Move Today?
Simply Wall St. · Oct 08
Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?
Zacks · Oct 07

Key stats

Market value$1.5B
P/E (next 12 months, estimated)38.5
52-week range$7.48 – $133.04
Revenue growth (latest quarter vs a year ago)+7.2%
Dividend yieldNo dividend
Analyst consensusBuy (12)
Average analyst price target$115.83 (+28%)
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

Earnings

Next report: 2026-11-04 · during market · EPS est -0.80
24-1125-0225-0525-0825-1126-0226-0526-08-8.952.32
EstimateActual (beat)Actual (miss)
ReportEPS estActualSurprise
2026-08-050.272.15+691.5%
2026-05-060.932.32+150.0%
2026-02-25-6.85-8.95-30.7%
2025-11-04-3.36-6.40-90.7%
2025-08-04-2.66-6.30-137.0%
2025-05-060.16-0.21-233.2%
2025-02-25-5.32-6.25-17.5%
2024-11-07-2.14-6.98-225.7%

Quarterly revenue

QuarterRevenueYoY
2026-06-30$1.5B+7.2%
2026-03-31$1.4B–
2025-12-31$1.6B–
2025-09-30$1.4B–
2025-06-30$1.4B–
Rating changes
Upgrade
2026-09-15 · Bernstein upgraded AGL from Market Perform to Outperform
Reiterated
2026-08-24 · JP Morgan reiterated Underweight on AGL
Reiterated
2026-08-11 · Wells Fargo reiterated Overweight on AGL
Upgrade
2026-08-11 · Citigroup upgraded AGL from Sell to Neutral
Reiterated
2026-08-06 · Truist Securities reiterated Hold on AGL
Reiterated
2026-08-06 · Benchmark reiterated Buy on AGL

Third-party analyst actions, not Coteau's views. All rating changes

Insider trades
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-21 18:01:47 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Free. Not investment advice. Unsubscribe anytime.

coteau

Free to use. No card, no ads, no auto-renew.

Independent research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

Beta 0.9 · Oct 21, 2026